{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:04:21Z","timestamp":1794895461660,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Non-selective beta-blockers (NSBB) are used for primary prophylaxis in patients with liver cirrhosis and high-risk varices (HRVs). Assessing therapeutic response is challenging due to the invasive nature of hepatic venous pressure gradient (HVPG) measurement. This study aims to define a\u00a0noninvasive machine-learning based\u00a0approach to determine response to NSBB in patients with liver cirrhosis and HRVs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a prospective study on a cohort of cirrhotic patients with documented HRVs receiving NSBB treatment. Patients were followed-up with clinical and elastography appointments at 3, 6, and 12\u00a0months after NSBB treatment initiation. NSBB response was defined as stationary or downstaging variceal grading at the 12-month esophagogastroduodenoscopy (EGD). In contrast, non-response was defined as upstaging variceal grading at the 12-month EGD or at least one variceal hemorrhage episode during the 12-month follow-up. We chose cut-off values for univariate and multivariate model with 100% specificity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>According to least absolute shrinkage and selection operator (LASSO) regression, spleen stiffness (SS) and liver stiffness (LS) percentual decrease, along with changes in heart rate (HR) at 3\u00a0months were the most significant predictors of NSBB response. A decrease &gt;\u200911.5% in SS,\u2009&gt;\u200916.8% in LS, and\u2009&gt;\u200925.3% in HR was associated with better prediction of clinical response to NSBB. SS percentual decrease showed the highest accuracy (86.4%) with high sensitivity (78.8%) when compared to LS and HR. The multivariate model incorporating SS, LS, and HR showed the highest discrimination and calibration metrics (AUROC\u2009=\u20090.96), with the optimal cut-off of 0.90 (sensitivity 94.2%, specificity 100%, PPV 95.7%, NPV 100%, accuracy 97.5%).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12072-024-10649-7","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T17:02:29Z","timestamp":1714064549000},"page":"460-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting response to non-selective beta-blockers with liver\u2013spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9910-3514","authenticated-orcid":false,"given":"Mauro","family":"Giuffr\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Visintin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Masutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Monica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisung","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Shung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lory Saveria","family":"Croc\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The NSBB-Elasto-Response-Prediction Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Abazia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Faini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Campigotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Dottor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gulotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma Valeria","family":"Albergati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Shung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"10649_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G,  Abraldes JG,  Berzigotti A. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310\u2013335.","journal-title":"Hepatology"},{"key":"10649_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-031-08552-9_6","volume-title":"HVPG as a gold standard: consensus statements of panel 1. Portal hypertension VII","author":"H Ferral","year":"2022","unstructured":"Ferral H,  Garcia-Pag\u00e0n JC,   Schepis F. HVPG as a gold standard: consensus statements of panel 1. Portal hypertension VII. Springer International Publishing: Cham;  2022. p. 61\u20134 .https:\/\/doi.org\/10.1007\/978-3-031-08552-9_6"},{"key":"10649_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2017.02.003","volume":"67","author":"A Berzigotti","year":"2017","unstructured":"Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol. 2017;67:399\u2013411.","journal-title":"J Hepatol"},{"key":"10649_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4202091","volume":"2018","author":"F Ravaioli","year":"2018","unstructured":"Ravaioli F,  Montagnani M,  Lisotti A. Noninvasive assessment of portal hypertension in advanced chronic liver disease: an update. Gastroenterol Res Pract. 2018;2018:1\u201311.","journal-title":"Gastroenterol Res Pract"},{"key":"10649_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/HMER.S278077","volume":"13","author":"E Dajti","year":"2021","unstructured":"Dajti E,  Alemanni LV,  Marasco G. Approaches to the diagnosis of portal hypertension: non-invasive or invasive tests? Hepat Med. 2021;13:25\u201336.","journal-title":"Hepat Med"},{"key":"10649_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"Franchis de R. Expanding consensus in portal hypertension. J Hepatol. 2015;63:743\u2013752.","journal-title":"J Hepatol"},{"key":"10649_CR7","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1007\/s00330-020-07223-8","volume":"31","author":"X Hu","year":"2021","unstructured":"Hu X,  Huang X,  Hou J. Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis. Eur Radiol. 2021;31:2392\u20132404.","journal-title":"Eur Radiol"},{"key":"10649_CR8","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5985.20.02773-7","author":"M Giuffr\u00e8","year":"2021","unstructured":"Giuffr\u00e8 M,  Colecchia A,  Croc\u00e8 LS.  Elastography: where are we now? Minerva Gastroenterol. 2021. https:\/\/doi.org\/10.23736\/S2724-5985.20.02773-7","journal-title":"Minerva Gastroenterol."},{"key":"10649_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"Franchis de R,  Bosch J,  Garcia-Tsao G.  Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol. 2022;76:959\u2013974.","journal-title":"J Hepatol"},{"key":"10649_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.12.001","volume":"2","author":"SG Rodrigues","year":"2020","unstructured":"Rodrigues SG,   Mendoza YP,  Bosch J.  Beta-blockers in cirrhosis: evidence-based indications and limitations. JHEP Rep. 2020;2:100063.","journal-title":"JHEP Rep"},{"key":"10649_CR11","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1148\/radiol.14140008","volume":"273","author":"S-Y Choi","year":"2014","unstructured":"Choi S-Y , Jeong WK,  Kim Y. Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis. Radiology. 2014;273:917\u2013926.","journal-title":"Radiology"},{"key":"10649_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7384144","volume":"2022","author":"A Binzberger","year":"2022","unstructured":"Binzberger A,  H\u00e4nle M,  Pfahler M. Spleen and liver stiffness evaluation by ARFI imaging: a reliable tool for a short-term monitoring of portal hypertension? Int J Hepatol. 2022;2022:1\u201314.","journal-title":"Int J Hepatol"},{"key":"10649_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s12072-020-10062-w","volume":"14","author":"G Marasco","year":"2020","unstructured":"Marasco G,  Dajti E,  Ravaioli F. Spleen stiffness measurement for assessing the response to \u03b2-blockers therapy for high-risk esophageal varices patients. Hepatol Int. 2020;14:850\u2013857.","journal-title":"Hepatol Int"},{"key":"10649_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jhep.2018.10.018","volume":"70","author":"HY Kim","year":"2019","unstructured":"Kim HY, So YH , Kim W.  Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. J Hepatol. 2019;70:412\u2013422.","journal-title":"J Hepatol"},{"key":"10649_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.diii.2017.03.003","volume":"98","author":"C Aub\u00e9","year":"2017","unstructured":"Aub\u00e9 C,   Bazeries P,   Lebigot J.  Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance. Diagn Interv Imaging. 2017;98:455\u2013468.","journal-title":"Diagn Interv Imaging"},{"key":"10649_CR16","doi-asserted-by":"publisher","first-page":"175628482211406","DOI":"10.1177\/17562848221140657","volume":"15","author":"G Ferraioli","year":"2022","unstructured":"Ferraioli G,  Roccarina  D.  Update on the role of elastography in liver disease. Therap Adv Gastroenterol. 2022;15:175628482211406.","journal-title":"Therap Adv Gastroenterol"},{"key":"10649_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RNH Pugh","year":"2005","unstructured":"Pugh RNH , Murray-Lyon  IM,  Dawson JL.  Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 2005;60:646\u2013649.","journal-title":"Br J Surg"},{"key":"10649_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS,  Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797\u2013805.","journal-title":"Hepatology"},{"key":"10649_CR19","doi-asserted-by":"crossref","unstructured":"De Franchis R, Abraldes JG, Bajaj J, et al. Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;743\u2013752.","DOI":"10.1007\/978-3-319-23018-4"},{"key":"10649_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/gastro\/gow018","volume":"4","author":"C Abby Philips","year":"2016","unstructured":"Abby C, Philips  Sahney  A. Oesophageal and gastric varices: historical aspects, classification and grading: everything in one place. Gastroenterol Rep (Oxf).  2016;4:186\u2013195.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10649_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.aohep.2019.03.004","volume":"18","author":"M Giuffr\u00e8","year":"2019","unstructured":"Giuffr\u00e8 M,  Macor D,  Masutti F. Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography. Ann Hepatol. 2019 ;18:736\u2013741.","journal-title":"Ann Hepatol"},{"key":"10649_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.aohep.2019.09.004","volume":"19","author":"M Giuffr\u00e8","year":"2020","unstructured":"Giuffr\u00e8 M,   Macor D,  Masutti F.  Spleen Stiffness Probability Index (SSPI): a simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis. Ann Hepatol. 2020;19:53\u201361.","journal-title":"Ann Hepatol"},{"key":"10649_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/microorganisms8030348","volume":"8","author":"M Giuffr\u00e8","year":"2020","unstructured":"Giuffr\u00e8 M,   Fouraki S,   Comar M.  The Importance of transaminases flare in liver elastography: characterization of the probability of liver fibrosis overestimation by hepatitis C virus-induced cytolysis. Microorganisms. 2020;8:348.","journal-title":"Microorganisms"},{"key":"10649_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/diagnostics10100795","volume":"10","author":"M Giuffr\u00e8","year":"2020","unstructured":"Giuffr\u00e8 M,  Giuricin M,  Bonazza D.  Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery. Diagnostics. 2020;10:795.","journal-title":"Diagnostics"},{"key":"10649_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.aohep.2020.07.004","volume":"19","author":"M Giuffr\u00e8","year":"2020","unstructured":"Giuffr\u00e8 M,  Bedogni G,   Abazia C.   Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension. Ann Hepatol. 2020;19:691\u2013693.","journal-title":"Ann Hepatol"},{"key":"10649_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40477-020-00456-9","volume":"24","author":"M Giuffr\u00e8","year":"2021","unstructured":"Giuffr\u00e8 M,  Fouraki S,  Campigotto M.  Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis. J Ultrasound. 2021;24:67\u201373.","journal-title":"J Ultrasound"},{"key":"10649_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1148\/radiol.2020192437","volume":"296","author":"RG Barr","year":"2020","unstructured":"Barr RG ,  Wilson SR,   Rubens D. Update to the Society of radiologists in ultrasound liver elastography consensus statement. Radiology. 2020;296:263\u2013274.","journal-title":"Radiology"},{"key":"10649_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS,  Wilk MB.  An analysis of variance test for normality (complete samples). Biometrika. 1965;52:591\u2013611.","journal-title":"Biometrika"},{"key":"10649_CR29","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.4103\/jfmpc.jfmpc_433_21","volume":"10","author":"A Najmi","year":"2021","unstructured":"Najmi A, Sadasivam B,   Ray A. How to choose and interpret a statistical test? An update for budding researchers.  J Family Med Prim Care. 2021;10:2763.","journal-title":"J Family Med Prim Care"},{"key":"10649_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J Roy Stat Soc: Ser B (Methodol). 1996;58:267\u2013288.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"10649_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00535-011-0517-4","volume":"47","author":"T Reiberger","year":"2012","unstructured":"Reiberger T,  Ferlitsch A,  Payer BA. Non-selective \u03b2-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis. J Gastroenterol.   2012;47:561\u2013568.","journal-title":"J Gastroenterol"},{"key":"10649_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011510.pub2","author":"AP Zacharias","year":"2018","unstructured":"Zacharias AP,  Jeyaraj R,  Hobolth L. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochr Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD011510.pub2.","journal-title":"Cochr Database Syst Rev."}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10649-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:59:08Z","timestamp":1750928348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10649"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10649-7","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mauro Giuffr\u00e8, Johannes Dupont, Alessia Visintin, Flora Masutti, Fabio Monica, Kisung You, Dennis L. Shung, Lory Saveria Croc\u00e8  have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the ethical principles for medical research involving human subjects as indicated by the Declaration of Helsinki. The study was carried out following the guidelines of the local Ethics Committee for conducting research involving humans (Protocol Number: 2783).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained for each patient participating in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}